Walleye Trading’s ChemoCentryx, Inc. CCXI Stock Holding History

Walleye Trading’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-2,700	Closed	-$139K	–	5802
2022 Q3	$139K	Hold	2,700	–	–	﹤0.01%	3918
2022 Q2	$67K	Sell	2,700 -10,000	-79%	-$220K	﹤0.01%	4245
2022 Q1	$318K	Sell	12,700 -17,900	-58%	-$503K	﹤0.01%	3398
2021 Q4	$1.11M	Buy	30,600 +25,300	+477%	+$888K	﹤0.01%	2146
2021 Q3	$91K	Buy	+5,300	New	+$82.6K	﹤0.01%	4413
2021 Q1	–	Sell	-1,000	Closed	-$62K	–	5520
2020 Q4	$62K	Buy	1,000 +800	+400%	+$45.8K	﹤0.01%	4120
2020 Q3	$11K	Buy	+200	New	+$10.8K	﹤0.01%	3906

Other funds holding CCXI

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Walleye Trading's CCXI Position: Q4 2022 in Review

Walleye Trading sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 45,348 shares — an estimated $2.34M sold.

Walleye Trading first reported a position in CCXI in Q4 2016 and held it in 10 quarters. The position peaked at $2.34M in Q3 2022. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

Walleye Trading reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
Walleye Trading sold 45,348 ChemoCentryx, Inc. shares in Q4 2022, an estimated $2.34M.
Walleye Trading first reported a position in ChemoCentryx, Inc. in Q4 2016 and held it in 10 quarters.
Walleye Trading's ChemoCentryx, Inc. position peaked at $2.34M in Q3 2022.
1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on Walleye Trading's 13F filing for Q4 2022, filed 14 Feb 2023.